Systematic review of the risk of adverse outcomes associated with vascular endothelial growth factor inhibitors for the treatment of cancer.

Systematic review of the risk of adverse outcomes associated with vascular endothelial growth factor inhibitors for the treatment of cancer.

BACKGROUND: Anti-angiogenic therapy targeted at vascular endothelial growth factor (VEGF) is now used to treat several types of cancer. We did a systematic review of randomized controlled trials (RCTs) to summarize the adverse effects of vascular endothelial growth factor inhibitors (VEGFi), focusin...

Full description

Bibliographic Details
Main Authors: Labib Imran Faruque, Meng Lin, Marisa Battistella, Natasha Wiebe, Tony Reiman, Brenda Hemmelgarn, Chandra Thomas, Marcello Tonelli
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4079504?pdf=render

Internet

http://europepmc.org/articles/PMC4079504?pdf=render

Similar Items